Key result
Dysfunctional adipocytes, ectopic fat accumulation, and adipose tissue resistance to insulin's antilipolytic effect play a central role in the development of impaired glucose metabolism.
Adipose tissue composition and function, rather than just total fat mass, are critical determinants in the development of metabolic diseases.
Answers are grounded in this paper and cite their sources.
May guide adipose-targeted metabolic research; leaves open interventional trials before clinical application.
Excess caloric intake does not always translate to an expansion of the subcutaneous adipose tissue (SAT) and increase in fat mass. It is now recognized that adipocyte type (white, WAT, or brown, BAT), size (large vs. small) and metabolism are important factors for the development of cardiometabolic diseases. When the subcutaneous adipose tissue is not able to expand in response to increased energy intake the excess substrate is stored as visceral adipose tissue or as ectopic fat in tissues as muscle, liver and pancreas. Moreover, adipocytes become dysfunctional (adiposopathy, or sick fat), adipokines secretion is increased, fat accumulates in ectopic sites like muscle and liver and alters insulin signaling, increasing the demand for insulin secretion. Thus, there are some subjects that despite having normal weight have the metabolic characteristics of the obese (NWMO), while some obese expand their SAT and remain metabolically healthy (MHO). In this paper we have reviewed the recent findings that relate the metabolism of adipose tissue and its composition to metabolic diseases. In particular, we have discussed the possible role of dysfunctional adipocytes and adipose tissue resistance to the antilipolytic effect of insulin on the development of impaired glucose metabolism. Finally we have reviewed the possible role of BAT vs. WAT in the alteration of lipid and glucose metabolism and the recent studies that have tried to stimulate browning in human adipose tissue.
No takes yet. Share an insight, caveat, or question.
Gaggini et al. (2017) conducted a review in Metabolic diseases. Adipose tissue metabolism and composition was evaluated. Dysfunctional adipocytes, ectopic fat accumulation, and adipose tissue resistance to insulin's antilipolytic effect play a central role in the development of impaired glucose metabolism.
Synapse has enriched 10 related papers. Consider them for comparative context: